Drug shortages and recalls are no longer isolated disruptions. They have become persistent features of the pharmaceutical supply chain, affecting how pharmacies manage inventory, respond to safety issues and protect financial performance.
Recent returns data shared by Inmar and published in the 96th edition of the HDA Factbook, along with insights discussed during a November 2025 industry webinar, shows how closely shortages and recalls are now tied to the returns process. As these events become more frequent and time-sensitive, returns are increasingly where operational pressure shows up first.
For pharmacies, the ability to manage returns effectively during shortages and recalls is becoming a measure of readiness, resilience and risk control.
Drug Shortages Are Showing Up More Often in Returns
Drug shortages are often discussed in terms of access and patient impact. Less attention is paid to how shortages affect pharmacy operations once products are removed from inventory.
In 2024, about 7 percent of unsaleable pharmaceutical returns were tied to drugs listed on the FDA’s drug shortages database. This is a notable increase from the prior year, when shortages accounted for just over 4 percent of returns.
The impact is not evenly distributed. Hospitals, in particular, saw a sharp rise in returns related to shortages, with nearly 21 percent of unsaleable hospital returns tied to shortage drugs. Retail pharmacies saw a much smaller share, reflecting differences in drug mix, patient acuity and inventory practices.
These figures highlight an important shift: shortages are no longer a background issue. They are actively shaping what enters the returns stream.
Shortages Increase Complexity, Not Just Volume
When a drug is in short supply, every unit carries more weight. Decisions around use, substitution and removal from inventory must be made quickly, often under changing guidance.
From a returns perspective, shortages create several challenges:
- Products may be pulled from shelves earlier than planned
- Eligibility for credit may depend on rapidly changing policies
- Documentation requirements may increase as scrutiny rises
These factors add complexity at a time when pharmacy staff are already under pressure. Returns tied to shortages require careful coordination to avoid unnecessary waste or missed recovery opportunities.
Recalls Are Increasing—and Moving Faster
Recalls remain a critical patient safety issue, and recent data shows they are becoming both more frequent and more time-sensitive.
In 2024, there were 319 pharmaceutical recalls, up from 281 the year before. Much of this growth came from Class II recalls, which occur at the pharmacy level and require prompt action to remove affected products from use.
At the same time, the average recall return window dropped significantly, from 113 days to just 64 days. This shorter window reflects faster detection and response across the industry, but it also leaves less room for delay or error.
For pharmacies, shorter timelines mean recall-related returns must be handled quickly and accurately. Delays can increase compliance risk and complicate reconciliation.
Why Recall Speed Matters for Returns
Faster recall response is a positive development for patient safety. It also raises the bar for returns management.
When recall windows shrink:
- Inventory must be identified and isolated quickly
- Returns must be processed within tighter deadlines
- Documentation must be complete and accurate on the first pass
Returns workflows that rely on manual steps or inconsistent practices are more likely to struggle under these conditions. What once could be resolved over weeks may now need to be handled in days.
The Financial Impact of Recall-Driven Returns
While recalls are primarily about safety, they also carry financial implications.
Returned recalled products often represent high-value inventory. Missing eligibility windows, incomplete documentation or processing delays can turn recoverable value into uncreditable loss.
As recall activity increases, the financial exposure associated with returns grows as well. This makes it especially important for returns processes to function smoothly during high-pressure situations.
When Shortages and Recalls Overlap
In some cases, shortages and recalls intersect, further complicating the returns landscape.
A recalled product that is also in short supply may trigger additional scrutiny and urgency. Decisions around removal, replacement and return may need to happen simultaneously, often with incomplete information.
In these scenarios, returns become a critical control point. Clear processes and reliable data help pharmacies respond effectively without introducing new risks.
Returns as a Measure of Operational Readiness
The growing role of shortages and recalls in the returns process underscores a broader point: returns reflect how prepared a pharmacy is to handle disruption.
Returns workflows touch multiple parts of the organization, including inventory management, compliance, finance and pharmacy operations. When these workflows are well coordinated, pharmacies can respond to shortages and recalls with greater confidence. When they are fragmented, stress points become visible quickly.
In this way, returns serve as a practical test of operational readiness.
Building Resilience Through Better Returns Practices
Drug shortages and recalls are unlikely to disappear. As they continue to shape the pharmaceutical landscape, returns will remain a key area where pressure concentrates.
Pharmacies that treat returns as an afterthought may find themselves reacting to problems as they arise. Those that view returns as an integrated, data-informed process are better positioned to manage disruption, protect value and maintain compliance.
Improving returns practices does not eliminate shortages or recalls. It does, however, help pharmacies navigate these challenges with greater clarity and control.
A Higher-Stakes Environment for Returns
The data makes one thing clear: returns are no longer just about clearing expired inventory. They sit at the intersection of patient safety, compliance and financial stewardship.
As drug shortages persist and recall activity accelerates, the stakes for returns management continue to rise. Pharmacies that recognize this shift can use returns as a tool for resilience, rather than a source of ongoing risk.
Optimize your pharmacy returns process